title: Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis.
authors.forename: O
authors.initials: O
authors.lastname: Meynet
authors.forename: M
authors.initials: M
authors.lastname: Bénéteau
authors.forename: M A
authors.initials: MA
authors.lastname: Jacquin
authors.forename: L A
authors.initials: LA
authors.lastname: Pradelli
authors.forename: A
authors.initials: A
authors.lastname: Cornille
authors.forename: M
authors.initials: M
authors.lastname: Carles
authors.forename: J-E
authors.initials: JE
authors.lastname: Ricci
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D006019:Glycolysis; D006801:Humans; D008223:Lymphoma / Q000473:pathology*; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009596:Nitrophenols / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: C501332:ABT-737; D001713:Biphenyl Compounds; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D009596:Nitrophenols; D010879:Piperazines; D019253:Proto-Oncogene Proteins c-bcl-2; D013449:Sulfonamides